Decreased expression of Bax and BH3-only pro-apoptotic Bcl-2 family proteins or increased expression of Bcl-2 and Mcl-1-related anti-apoptotic Bcl-2 family proteins predicts poor clinical outcome in patients with malignant glioma [3,38,39,40]. The gene discussed is BAX; the disease is malignant glioma.